Tottenham Acquisition I today filed supplemental details in its proxy to shareholders in advance of a Dec. 30 vote on whether to merge with Clene Nanomedicine. The additional information outlines the exercise of options and share conversions that will impact the number of issuable shares post-merger. Read more.
Related Posts
Aquarius I Acquisition Files for $50M IPO
The new SPAC in the filing said it iwll target high growth businesses with enterprise values between $150 million and $300 million.
MedTech Co. Vaso Combining with Achari Ventures Holdings I in $176M Deal
The target is a diversified medical technology company with several specialties.
SportsMap Tech Acquisition Secures $6.8M in Financing to Support Infrared Cameras Deal
The target is a provider of intelligent thermal imaging platforms. As announced last December, the deal values the merged company at $100 million.
AERWINS Technologies Merging with Pono Capital in $750M Deal
The SPAC less than a month ago terminated a merger deal with pharmaceutical cannabinoids company Benuvia by mutual agreement. That deal had a pro forma enterprise valuation of $440 million.